SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
HemCon Medical Technologies, Inc. and Zeria Pharmaceutical Co., Ltd. Sign Exclusive Licensing Agreement for HemCon’s Innovative Product Line in Japan
Your Message